Sign for Notice Everyday    Sign Up| Sign In| Link| English|

Our Sponsors

    Receive Latest News

    Feedburner
    Share Us


    The Veterinary Drug Approval Process and FDA Regulatory Oversight

    View: 326

    Website https://www.complianceonline.com/the-veterinary-drug-approval-process-and-fda-regulatory-oversight-s | Want to Edit it Edit Freely

    Category

    Deadline: February 24, 2020 | Date: March 05, 2020-March 06, 2020

    Venue/Country: Orlando, FL, U.S.A

    Updated: 2020-01-02 23:28:50 (GMT+9)

    Call For Papers - CFP

    The U.S. Food and Drug Administration’s Center for Veterinary Medicine (CVM) is responsible for the approval of veterinary drug products intended for both family pets and food-producing animals. However, FDA does not regulate all products intended for animal use. Jurisdiction over animal products including licensed biologics such as vaccines is shared with a number of other federal agencies. For example, animal vaccines, animal disease diagnostic devices and some animal biologics are regulated by the U.S. Department of Agriculture’s Animal and Plant Health Inspection Service or APHIS; and products such as flea and tick collars are regulated by the Environmental Protection Agency.

    This seminar on veterinary medicine regulations will provide attendees with an understanding of FDA’s veterinary drug approval process. This two day interactive course will cover:

    Premarket approval process

    Various sections of a New Animal Drug Application

    Strategies for navigating the FDA approval process


    Keywords: Accepted papers list. Acceptance Rate. EI Compendex. Engineering Index. ISTP index. ISI index. Impact Factor.
    Disclaimer: ourGlocal is an open academical resource system, which anyone can edit or update. Usually, journal information updated by us, journal managers or others. So the information is old or wrong now. Specially, impact factor is changing every year. Even it was correct when updated, it may have been changed now. So please go to Thomson Reuters to confirm latest value about Journal impact factor.